| Bioactivity | Menin-MLL inhibitor 21(example 9) is a specific irreversible inhibitor of Menin-MLL interactions and can be used in the study of autoimmune diseases, alloimmune diseases, cancer and other diseases dependent on menin-MLL[1]. | |||||||||
| Name | Menin-MLL inhibitor 21 | |||||||||
| CAS | 2448172-22-1 | |||||||||
| Formula | C31H34N8O3 | |||||||||
| Molar Mass | 566.65 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Thomas Butler, et al. Irreversible inhibitors of menin-mll interaction.WO2020142557 A1. |
Menin-MLL inhibitor 21
CAS: 2448172-22-1 F: C31H34N8O3 W: 566.65
Menin-MLL inhibitor 21(example 9) is a specific irreversible inhibitor of Menin-MLL interactions and can be used in the
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.